FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
227 letters match. Newest first.
-
DrugsClinical Resolution Laboratory Inc.
FDA warned Clinical Resolution Laboratory in Brea, CA, about CGMP failures and unapproved OTC drugs.
High risk -
DrugsElements Brands Inc.
FDA warned Elements Brands that its eb5 Skin Lightening Cream is an unapproved, misbranded new drug.
High risk -
DrugsUltimark Products
Ultimark Products sells Porcelana Day Skin Lightening Cream, an unapproved and misbranded hydroquinone skin-bleaching drug, FDA says.
High risk -
DrugsClinical Formula LLC
FDA warned Clinical Formula LLC that its Clinical Formula Bleaching Lotion is an unapproved and misbranded skin-lightening drug.
Medium -
DrugsDr. Thomas Balshi/Intilight
FDA warned Dr. Thomas Balshi/Intilight that its hydroquinone skin-lightening cream is an unapproved and misbranded new drug.
High risk -
DrugsSkin Authority, L.L.C.
FDA warns Skin Authority that its skinauthority Hyperpigmentation Treatment is an unapproved and misbranded skin-bleaching drug.
High risk -
DrugsAMBI Enterprises LLC
AMBI sold two unapproved hydroquinone skin-bleaching fade creams with unlawful labeling, FDA says.
High risk -
DrugsGenomma Lab USA, Inc.
Genomma Lab USA sold two hydroquinone skin-lightening creams as unapproved and misbranded new drugs, FDA says.
High risk -
DrugsVi-Jon, LLC
FDA cited Vi-Jon for manufacturing-rule violations after finding microbial water contamination, leaks, weak investigations, and data-integrity failures in OTC drugs and cosmetics.
High risk -
DrugsUltra Seal Corporation
FDA warns Ultra Seal and ULTRAtab over manufacturing quality failures in over-the-counter drug cleaning, testing, and release.
High risk -
DrugsYusef Manufacturing Laboratories, LLC
FDA warned Yusef Manufacturing Laboratories over serious CGMP violations in its OTC drugs and hand sanitizers, including untested ethanol.
High risk -
DrugsAccu Bio-Chem Laboratories
FDA warned Accu Bio-Chem Laboratories, a contract OTC drug-testing lab, over inadequate failing-result investigations, method verification, and data controls.
Medium -
DrugsCES LLC
CES LLC’s alcohol-based hand sanitizer is misleadingly packaged in an 8.45-ounce bottle that resembles a drinking water bottle.
High risk -
DrugsGenesis Partnership Company SA
Genesis Partnership's Bathletix hand sanitizer is misbranded because its bottle resembles a drinking water bottle.
High risk -
DrugsMaquiladora Miniara SA de CV
Maquiladora Miniara's Shine and clean Hand Sanitizer Gel was found to contain methanol instead of labeled ethanol.
High risk -
DrugsHealthMEDS Inc.
HealthMEDS Inc., an over-the-counter drug maker, failed to provide FDA-requested records and did not respond to repeated FDA contacts.
Medium -
DrugsTrue Chemical Solutions, LLC
FDA cites True Chemical Solutions over unanswered hand sanitizer records requests.
Medium -
DrugsLaboratorio Pharma International SRL
FDA warns Laboratorio Pharma International over CGMP failures, unapproved GELAZUL, misbranding, and incomplete beta-lactam separation.
High risk -
DrugsFurley Bioextracts SDN BHD
FDA warns Furley Bioextracts over manufacturing failures and unapproved PainFix Relief Gel for the U.S. market.
High risk -
DrugsNatural Beauty Care Pty Ltd
FDA warned Natural Beauty Care Pty Ltd that its OTC drugs are adulterated due to CGMP failures and no finished-product or ingredient testing.
High risk -
DrugsBBC Group Limited
FDA cites BBC Group Limited for data integrity, lab, equipment failures and unapproved, misbranded hand sanitizers.
High risk -
DrugsHalodine, LLC
Halodine, LLC marketed unapproved nasal and oral antiseptic drugs with COVID-19 prevention and treatment claims, FDA says.
High risk -
DrugsBiotek India
Biotek India, an OTC drug maker, lacked active-ingredient testing and sold an unapproved 99% isopropyl rubbing alcohol.
High risk -
DrugsDibar Nutricional S. de R.L. de C.V.
Dibar Nutricional's OTC drugs drew FDA CGMP violations and an import alert over missing testing.
High risk -
DrugsYara Elena De La Garza Perez Nieto
FDA found Yara Elena De La Garza Perez Nieto's DAESI Hand Sanitizer contained methanol instead of labeled ethanol and was adulterated and misbranded.
High risk -
DrugsAbsara Cosmetics S.A.P.I DE C.V.
Absara Cosmetics' hand sanitizer labeled 70% ethanol tested at 58%, leading to CGMP citations.
High risk -
DrugsYuyao YiJia Daily Chemical Co., Ltd.
Yuyao YiJia, a Chinese OTC drug and hand sanitizer maker, lacked finished-product, component and stability testing and an adequate quality unit.
High risk